Afleveringen
-
Bryan Dechairo, Chief Executive Officer of Sherlock Biosciences on point discussing his vision to offer open-source product development to biomedical companies on their platform which will be enabled by artificial intelligence.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Bryan Dechairo, Chief Executive Officer of Sherlock Biosciences on point discussing his sources of funding and their focus on global health issues.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Zijn er afleveringen die ontbreken?
-
Bryan Dechairo, Chief Executive Officer of Sherlock Biosciences on point discussing his vision to bend the curve on population health with accurate, affordable, and accessible diagnostic tests.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Julie Garlikov, Chief Commercial Officer of Sherlock Biosciences on point discussing providing healthcare access to underserved communities.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Bryan Dechairo, Chief Executive Officer of Sherlock Biosciences on point discussing their application of CRISPR which was the first ever FDA authorized use of the technology.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Bryan Dechairo, Chief Executive Officer of Sherlock Biosciences on point discussing the challenges commercializing high-tech, low-cost products.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Bryan Dechairo, Chief Executive Officer of Sherlock Biosciences on point discussing the challenges commercializing high-tech, low-cost products.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Bryan Dechairo, Chief Executive Officer of Sherlock Biosciences on point discussing how they plan to provide access to health information with diagnostic tests.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Bryan Dechairo, Chief Executive Officer of Sherlock Biosciences on point discussing how they plan to provide access to health information with diagnostic tests.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Julie Garlikov, Chief Commercial Officer of Sherlock Biosciences on point discussing raising the stakes in the diagnostics industry.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Julie Garlikov, Chief Commercial Officer of Sherlock Biosciences on point discussing raising the stakes in the diagnostics industry.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Julie Garlikov, Chief Commercial Officer of Sherlock Biosciences on point discussing improving the user experience in diagnostic testing.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Julie Garlikov, Chief Commercial Officer of Sherlock Biosciences on point discussing improving the user experience in diagnostic testing.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Bryan Dechairo, Chief Executive Officer of Sherlock Biosciences on point discussing his role as a life sciences CEO.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Bryan Dechairo, Chief Executive Officer of Sherlock Biosciences on point discussing his role as a life sciences CEO.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Bryan Dechairo, Chief Executive Officer of Sherlock Biosciences on point discussing his vision for the future of your healthcare journey with accurate, affordable, accessible diagnostic tests.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Bryan Dechairo, Chief Executive Officer of Sherlock Biosciences on point discussing his vision for the future of your healthcare journey with accurate, affordable, accessible diagnostic tests.
From Episode 11 of Boyd Biomedical Design Stories. Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
On this episode of Boyd Biomedical Design Stories, Matthew Boyd and Rachel Robinson are joined by Bryan Dechairo and Julie Garlikov from Sherlock Biosciences. They discuss Sherlock Biosciences' approach to molecular diagnostics using CRISPR, synthetic biology, artificial intelligence and more.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Bryan Dechairo is the Chief Executive Officer and serves on the Board of Directors of Sherlock Biosciences. Bryan has over 20 years of experience developing and commercializing clinical innovations and has authored more than 50 academic and research-based publications.
Julie Garlikov is the Chief Commercial Officer of Sherlock Biosciences. Julie is a global marketing and sales expert with more than 20 years of experience in product commercialization, especially in consumer health and wellness brands.
WATCH THE FULL EPISODE WITH VIDEO
Watch
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
X
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Carmichael Roberts, co-founder and investor in Arsenal Medical on point sharing his insight on investing in what you know and the opportunities for investors in biomaterials innovation.
From Episode 10 of Boyd Biomedical Design Stories. Matthew Boyd and Brian Johnson are joined by Dr. Upma Sharma and Carmichael Roberts from Arsenal Medical. They discuss Arsenal Medical’s approach to a few long-standing clinical problems with their novel biomaterials and devices.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Upma Sharma is the President and CEO of Arsenal Medical. Upma has dedicated her career to transforming medicine with materials. Under her leadership, Arsenal Medical has achieved FDA breakthrough device status and IDE approval for ResQFoam™ and secured over $65M in funding. She has also advanced a new biomaterial for neurovascular diseases into the clinic.
Carmichael Roberts is co-founder and managing partner of Material Impact an early-stage investment company focused on chemistry and materials inventions. He is a successful serial entrepreneur and venture capitalist and is a co-founder of Arsenal Medical.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
Twitter
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
-
Carmichael Roberts, co-founder and investor in Arsenal Medical on point sharing his perspective on the challenges and benefits for start-ups who attract government funding.
From Episode 10 of Boyd Biomedical Design Stories. Matthew Boyd and Brian Johnson are joined by Dr. Upma Sharma and Carmichael Roberts from Arsenal Medical. They discuss Arsenal Medical’s approach to a few long-standing clinical problems with their novel biomaterials and devices.
SUBSCRIBE TO BOYD BIOMEDICAL DESIGN STORIES
Subscribe
Upma Sharma is the President and CEO of Arsenal Medical. Upma has dedicated her career to transforming medicine with materials. Under her leadership, Arsenal Medical has achieved FDA breakthrough device status and IDE approval for ResQFoam™ and secured over $65M in funding. She has also advanced a new biomaterial for neurovascular diseases into the clinic.
Carmichael Roberts is co-founder and managing partner of Material Impact an early-stage investment company focused on chemistry and materials inventions. He is a successful serial entrepreneur and venture capitalist and is a co-founder of Arsenal Medical.
LISTEN TO THE AUDIO ONLY PODCAST
Apple Podcasts
Google Podcasts
Spotify
FOLLOW US ON SOCIAL MEDIA
LinkedIn
Facebook
Twitter
LEARN MORE
Our articles and resources explore materials, technologies, design, and manufacturing in the life sciences. Together, we're advancing biomedical innovation through curiosity and shared knowledge.
Be Curious
- Laat meer zien
